State Street’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.2M | Buy |
8,505,392
+691,988
| +9% | +$6.2M | ﹤0.01% | 1458 |
|
|
2025
Q1 | $58.6M | Buy |
7,813,404
+314,437
| +4% | +$2.36M | ﹤0.01% | 1561 |
|
|
2024
Q4 | $56.4M | Sell |
7,498,967
-1,350,621
| -15% | -$10.2M | ﹤0.01% | 1653 |
|
|
2024
Q3 | $67.3M | Sell |
8,849,588
-497,211
| -5% | -$3.78M | ﹤0.01% | 1552 |
|
|
2024
Q2 | $57.8M | Sell |
9,346,799
-8,130,545
| -47% | -$50.2M | ﹤0.01% | 1594 |
|
|
2024
Q1 | $88.8M | Buy |
17,477,344
+4,700,341
| +37% | +$23.9M | ﹤0.01% | 1385 |
|
|
2023
Q4 | $76.5M | Buy |
12,777,003
+2,310,625
| +22% | +$13.8M | ﹤0.01% | 1467 |
|
|
2023
Q3 | $74.1M | Sell |
10,466,378
-1,797,591
| -15% | -$12.7M | ﹤0.01% | 1377 |
|
|
2023
Q2 | $86.3M | Buy |
12,263,969
+874,346
| +8% | +$6.16M | ﹤0.01% | 1323 |
|
|
2023
Q1 | $95M | Buy |
11,389,623
+262,762
| +2% | +$2.19M | 0.01% | 1226 |
|
|
2022
Q4 | $128M | Buy |
11,126,861
+1,722,614
| +18% | +$19.8M | 0.01% | 1017 |
|
|
2022
Q3 | $118M | Sell |
9,404,247
-1,600,556
| -15% | -$20.2M | 0.01% | 1009 |
|
|
2022
Q2 | $116M | Buy |
11,004,803
+3,542,051
| +47% | +$37.5M | 0.01% | 1056 |
|
|
2022
Q1 | $121M | Sell |
7,462,752
-786,277
| -10% | -$12.8M | 0.01% | 1157 |
|
|
2021
Q4 | $114M | Buy |
8,249,029
+1,143,706
| +16% | +$15.8M | 0.01% | 1191 |
|
|
2021
Q3 | $102M | Buy |
7,105,323
+852,551
| +14% | +$12.3M | 0.01% | 1244 |
|
|
2021
Q2 | $98.9M | Sell |
6,252,772
-1,056,044
| -14% | -$16.7M | 0.01% | 1298 |
|
|
2021
Q1 | $74.3M | Sell |
7,308,816
-3,748,163
| -34% | -$38.1M | ﹤0.01% | 1457 |
|
|
2020
Q4 | $82.4M | Sell |
11,056,979
-5,126,994
| -32% | -$38.2M | 0.01% | 1296 |
|
|
2020
Q3 | $55.6M | Buy |
16,183,973
+605,578
| +4% | +$2.08M | ﹤0.01% | 1378 |
|
|
2020
Q2 | $74.2M | Buy |
15,578,395
+9,832,343
| +171% | +$46.9M | 0.01% | 1165 |
|
|
2020
Q1 | $11.5M | Buy |
5,746,052
+253,109
| +5% | +$506K | ﹤0.01% | 2197 |
|
|
2019
Q4 | $19M | Buy |
5,492,943
+631,167
| +13% | +$2.18M | ﹤0.01% | 2168 |
|
|
2019
Q3 | $13.9M | Sell |
4,861,776
-1,783,941
| -27% | -$5.11M | ﹤0.01% | 2300 |
|
|
2019
Q2 | $25.2M | Buy |
6,645,717
+3,135,675
| +89% | +$11.9M | ﹤0.01% | 1960 |
|
|
2019
Q1 | $28.6M | Buy |
3,510,042
+713,082
| +25% | +$5.8M | ﹤0.01% | 1815 |
|
|
2018
Q4 | $22.6M | Sell |
2,796,960
-598,741
| -18% | -$4.83M | ﹤0.01% | 1895 |
|
|
2018
Q3 | $25.9M | Sell |
3,395,701
-281,703
| -8% | -$2.15M | ﹤0.01% | 1993 |
|
|
2018
Q2 | $21.1M | Sell |
3,677,404
-827,310
| -18% | -$4.74M | ﹤0.01% | 2099 |
|
|
2018
Q1 | $21.5M | Buy |
4,504,714
+610,167
| +16% | +$2.91M | ﹤0.01% | 1997 |
|
|
2017
Q4 | $19.1M | Buy |
3,894,547
+926,962
| +31% | +$4.55M | ﹤0.01% | 2079 |
|
|
2017
Q3 | $15.5M | Sell |
2,967,585
-941,428
| -24% | -$4.93M | ﹤0.01% | 2189 |
|
|
2017
Q2 | $21.7M | Buy |
3,909,013
+1,636,909
| +72% | +$9.1M | ﹤0.01% | 1930 |
|
|
2017
Q1 | $19.1M | Buy |
2,272,104
+179,216
| +9% | +$1.51M | ﹤0.01% | 1972 |
|
|
2016
Q4 | $13.2M | Buy |
2,092,888
+744,580
| +55% | +$4.71M | ﹤0.01% | 2185 |
|
|
2016
Q3 | $5.95M | Buy |
1,348,308
+8,960
| +0.7% | +$39.5K | ﹤0.01% | 2463 |
|
|
2016
Q2 | $3.8M | Sell |
1,339,348
-3,984
| -0.3% | -$11.3K | ﹤0.01% | 2756 |
|
|
2016
Q1 | $3.8M | Sell |
1,343,332
-771,436
| -36% | -$2.18M | ﹤0.01% | 2698 |
|
|
2015
Q4 | $21.8M | Sell |
2,114,768
-1,037,545
| -33% | -$10.7M | ﹤0.01% | 1651 |
|
|
2015
Q3 | $35.9M | Sell |
3,152,313
-57,895
| -2% | -$660K | ﹤0.01% | 1354 |
|
|
2015
Q2 | $47.9M | Sell |
3,210,208
-131,004
| -4% | -$1.96M | 0.01% | 1299 |
|
|
2015
Q1 | $30.2M | Buy |
3,341,212
+550,777
| +20% | +$4.97M | ﹤0.01% | 1549 |
|
|
2014
Q4 | $33.9M | Buy |
2,790,435
+458,369
| +20% | +$5.57M | ﹤0.01% | 1433 |
|
|
2014
Q3 | $22.8M | Buy |
2,332,066
+84,612
| +4% | +$828K | ﹤0.01% | 1646 |
|
|
2014
Q2 | $28.7M | Buy |
2,247,454
+609,035
| +37% | +$7.76M | ﹤0.01% | 1563 |
|
|
2014
Q1 | $17.3M | Buy |
1,638,419
+1,579,735
| +2,692% | +$16.7M | ﹤0.01% | 1887 |
|
|
2013
Q4 | $446K | Buy |
58,684
+9,700
| +20% | +$73.7K | ﹤0.01% | 3371 |
|
|
2013
Q3 | $357K | Buy |
48,984
+7,700
| +19% | +$56.1K | ﹤0.01% | 3385 |
|
|
2013
Q2 | $64K | Buy |
+41,284
| New | +$64K | ﹤0.01% | 3413 |
|